Tuesday, December 9, 2008

Merck Jumps Into Generic Biotech

The drugmaker sees a "significant opportunity" from the expiration of patents on some biotech blockbusters between now and 2017.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)